Medico Intercontinental has received an approval for diversification into Pharmaceutical Industry and change in main object clause of the memorandum of association (MOA) of the company. The Board of Directors of the company at their meeting held on January 16, 2019, approved the same.
The company is a dynamic business organization operating in the field of financing, trading and investment in shares and securities.